EP1904521A2 - Nouvelles proteines bacteriennes avec activite pesticide - Google Patents

Nouvelles proteines bacteriennes avec activite pesticide

Info

Publication number
EP1904521A2
EP1904521A2 EP06795076A EP06795076A EP1904521A2 EP 1904521 A2 EP1904521 A2 EP 1904521A2 EP 06795076 A EP06795076 A EP 06795076A EP 06795076 A EP06795076 A EP 06795076A EP 1904521 A2 EP1904521 A2 EP 1904521A2
Authority
EP
European Patent Office
Prior art keywords
protein
plant
islp
amino acid
pests
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP06795076A
Other languages
German (de)
English (en)
Other versions
EP1904521B1 (fr
Inventor
Alejandra Ins. de Biotec. UNAM BRAVO-DE-LA-PARRA
Mario Ins. de Biotec. UNAM SOBERON-CHAVEZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO INSTITUTO
Original Assignee
UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO INSTITUTO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37637544&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP1904521(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO INSTITUTO filed Critical UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO INSTITUTO
Publication of EP1904521A2 publication Critical patent/EP1904521A2/fr
Application granted granted Critical
Publication of EP1904521B1 publication Critical patent/EP1904521B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8286—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
    • Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants

Definitions

  • the present invention relates to the field of pest control, particularly insect control.
  • plants comprising a nucleic acid molecule encoding an ISLP protein of the invention, as well as methods and means for using these nucleic acid sequences for reducing pest damage, such as insect damage, to plants.
  • Bacillus thuringiensis Bacillus thuringiensis
  • Bacillus thuringiensis Bacillus thuringiensis
  • the Bt Cry proteins are highly specific, harmless to humans, vertebrates and plants, and are completely biodegradable so no residual toxic products accumulate in the environment (Schnepf et al., 1998).
  • cry genes sequences have been determined and classified in 44 families and different subclasses (Crickmore et al., 1998, 2005).
  • Bt produces a number of extracellular compounds that might contribute to virulence as phospholipases, proteases, chitinases and other toxins as ⁇ -exotoxin or VIP proteins (Schnepf et al., 1998).
  • phospholipases phospholipases
  • proteases chitinases
  • VIP proteins ⁇ -exotoxin or VIP proteins
  • the S-layer is an ordered structure of proteinaceous paracrystalline array, which cover the surface of many archaea and eubacteria (Beveridge et al., 1997; Sara and Sleytr, 2000) and can constitute up to 15% of total cell protein.
  • the function of S- layer proteins has not been accurately defined, but it has been proposed that these proteins are involved in cell integrity and shape maintenance. Also, it has been hypothesized that they may be involved in macromolecular exchange with the environment since they are the outermost cell envelope component (Beveridge et al., 1997). In some gram-negative pathogenic bacteria, they have been implicated in virulence and resistance to complement-mediated killing (Sara and SLeytr, 2000; Pei and Blaser, 1990).
  • the S-layer has been described to promote interactions with human leucocytes and with the host, contributing to the pathogenicity (Kotiranta et al., 1998).
  • S. anthracis it has been proposed that the S-layer and the capsule might cooperate in the interaction with the host (Mignot et al., 2002).
  • B. anthracis two different S-Layer proteins (SAP and EA1 ) have been described (Mignot et al., 2002). The presence of these proteins is not required for normal encapsulation of the Bacilli (Mesnage et al., 1998). These proteins appear sequentially in a growth phase-dependent manner, with the synthesis of SAP preceding that of EA1 (Mignot et al., 2002).
  • B. thuringiensis subs galleria an S-Layer protein was described, SIpA, that is similar to the SAP of ⁇ . anthracis.
  • the S-layer CTC protein was described in B. thuringiensis subsp.
  • CTC has a molecular size of 100 kDa and forms parasporal bodies during the sporulation phase of growth.
  • nucleotide sequence of the gene encoding this protein is not provided but is said to encode 821 amino acid residues with a deduced molecular weight of 87.5 kDa.
  • isolated pesticidal ISLP proteins characterized by: a) being specifically pesticidal to some pests and not to others, and b) having at least 50 % sequence identity with a bacterial S-layer protein, as well as such proteins which have at least 50 % sequence identity to the protein of SEQ ID NO:2 or a toxic fragment thereof, and which have a molecular weight of about 50 to about 12O kDa.
  • isolated pesticidal ISLP proteins which are characterized by: a) being specifically insecticidal to some insects and not to others, b) having at least 70 % sequence identity to a bacterial S-layer protein, c) a molecular weight of about 50 to about 120 kDa, as well as such proteins which have at least 75 % sequence identity to the protein of SEQ ID NO:2 or a toxic fragment thereof, and which have a molecular weight of about 50 to about 120 kDa.
  • an ISLP pesticidal protein as defined above, comprising the amino acid sequence of SEQ ID NO: 2 from an amino acid position between amino acid position 1 and amino acid position 31 to amino acid position 863, or comprising the amino acid sequence of SEQ ID NO: 2 from an amino acid position between amino acid position 1 and amino acid position 531 to amino acid position 863, such as a protein comprising the amino acid sequence of SEQ ID NO: 2.
  • isolated DNA sequences encoding any of the above ISLP proteins and chimeric genes comprising: a) a coding sequence comprising such DNA, and b) a promoter which allows expression in plant cells.
  • such chimeric gene comprises a coding sequence which is a synthetic DNA sequence that has been optimized for expression in a host plant, particularly corn, cotton, soybean, rice, oilseed rape, cauliflower, and cabbage.
  • transgenic plant, seed or plant cell which comprise any of the above chimeric genes, particularly a plant, seed or cell of corn, cotton, soybean, rice, oilseed rape, cauliflower, and cabbage.
  • Also provided herein is a method of protecting plants against damage caused by plant pests, such as insect pests, feeding on the plant species to which said plants belong, comprising the step of expressing any of the above chimeric genes in cells of said plants; as well as a method of protecting plants against damage caused by plants pests, such as insect pests, feeding on the plant species to which said plants belong, comprising the step of transforming a plant cell with any of the above chimeric genes, regenerating said cell into a plant, and obtaining progeny and propagating material of said plant, such as seeds, comprising any of such chimeric genes.
  • a method for killing pests comprising contacting said pests with any of the above ISLP proteins, particularly when such pest is an insect pest; as well as a method to protect a field of plants from pests such as insects, comprising: applying any of the above ISLP proteins to a field of plants, either in the form of a pesticidal composition comprising such protein, or in the form of a recombinant organism expressing said protein, particularly wherein said organism is a transgenic plant expressing such protein.
  • the present invention provides methods and means for reducing damage to plants caused by pests, particularly insect pests, such as iepidopteran of coleopteran insect pests.
  • the present invention further provides novel nucleic acid sequences and proteins that are distinct from previously described nucleic acid sequences and proteins. These nucleic acids and proteins can be used for controlling pests such as insect pests, e.g., by integration and expression of at least one of these new nucleotide sequences in plants or plant cells, or by external treatment of plants or plant parts with compositions comprising the toxins encoded by these nucleic acid molecules.
  • nucleic acid sequence refers to a DNA or
  • RNA molecule in single- or double-stranded form, that encodes any of the ISLP proteins of this invention.
  • isolated nucleic acid sequence is not limited to a nucleic acid sequence in isolation, but also encompasses a nucleic acid sequence that is no longer in the natural environment where it was isolated from.
  • an "isolated ISLP nucleic acid (sequence)" or an “isolated ISLP protein (sequence) in accordance with this invention, includes the nucleic acid or protein (sequence) in another bacterial host , compared to the original bacterial organism, or in a plant nuclear genome.
  • protein or “polypeptide” are used interchangeably to refer to a molecule consisting of a chain of amino acids, without reference to any specific mode of action, size, three-dimensional structure or origin. Hence, a fragment or portion of an ISLP protein of the invention is still referred to herein as a "protein".
  • isolated protein is not limited to a protein in isolation, but also encompasses a protein that is no longer in its natural environment.
  • the natural environment of the protein refers to the environment in which the protein could be found in nature, i.e., in the strain from which the nucleotide sequence was originally isolated.
  • an isolated protein can be present in vitro, or in another bacterial host or in a plant cell, or it can be secreted from another bacterial host or from a plant cell.
  • nucleic acid sequences including DNA sequences, encoding new ISLP proteins have been isolated and characterized, and novel forms are artificially made by DNA synthesis.
  • a specific ISLP gene described herein was designated islpi and its encoded protein ISLP1.
  • an "ISLP” or “ISLP protein” is a pesticical, particularly an insecticidal, protein of about 40 to about 250 kDa, particularly of about 50 to about 120 kDa, or between about 60 to about 100 kDa, especially a protein of about 80 or about 100 kDa, isolated or derived from bacteria, preferably bacilli, with at least 50 %, at least 60 %, at least 70 %, at least 80 %, preferably at least 85 or 90 %, sequence identity or sequence similarity to a known S-layer protein, e.g., the CTC2 protein of B.
  • ISLP proteins include pesticidal, preferably insecticidal, proteins immunologically related to an ISLP protein, such that they are recognized by antibodies recognizing ISLPs.
  • the ISLPs of this invention preferably originate from or are found in (or on) bacteria of the class of Bacilli within the division of Firmicutes.
  • the ISLPs of this invention originate from or are found in (or on) bacteria of the Order Bacillales. In yet another embodiment of this invention, the ISLPs of this invention originate from or are found in (or on) bacteria of the family Bacillaceae. In a further embodiment of this invention, the ISLPs originate from or are found in (or on) bacteria of the Bacillus cereus group, or in (or on) bacteria of the genus Brevibacillus or Bacillus, preferably Bacillus cereus, B. sphaericus, B. anthracis, B. licheniformis and S. thu ⁇ ngiensis.
  • An ISLP protein in accordance with this invention can be produced in the vegetative and/or in the sporulation phase of the bacterial life cycle and in nature it is typically a secreted protein.
  • the toxicity of an ISLP protein is preferably specific, so that the ISLP is toxic for only some pests, preferably insects, and leaves non-target organisms, such as mammals, unaffected.
  • the ISLP protein is not toxic to mammals, or is readily degraded in mammalian digestive systems.
  • a "mature ISLP protein" as used herein, refers to an ISLP protein of this invention lacking its bacterial signal peptide.
  • An ISLP protein, as used herein, can be a protein in the full-length size or can be in a truncated form as long as the pesticidal, e.g., insecticidal, or pest- controlling, e.g., insect-controlling, activity is retained, or can be a combination of several proteins or protein domains in a hybrid or fusion protein.
  • an ISLP protein is a pesticidal protein, particularly an insecticidal protein, specifically toxic to some pests, preferably insects, which is capable of forming crystalline structures such as crystalline arrays or S-layers on the outside of a bacterial cell in nature.
  • such ISLPs can often be isolated or co-purified in a procedure for isolating bacterial, e.g., Bacillus thuringiensis (Bt), crystal/spore preparations, though they have no significant sequence identity, preferably less then 40 %, less then 30 % or less then 20 % sequence identity, to known bacterial pesticidal or insecticidal toxins such as Bacillus thuringiensis Cry, VIP or Cyt proteins (see Crickmore et al., 1998 and 2005) or to other known pesticidal or insecticidal bacterial, such as Bt, proteins.
  • Bt Bacillus thuringiensis
  • These ISLPs are found on the outer side of the bacterial cell wall in nature, and can be released in the environment of the bacteria or spores at sporulation.
  • an ISLP is a pesticidal, particularly insecticidal, protein comprising three S-layer homology (SLH) regions, each of such regions having at least 50 %, or at least 60 %, or at least 70 %, particularly at least 85 or 90 %, sequence identity or similarity to the S-layer homology regions in SEQ ID NO: 2.
  • S-Layer homology regions are the region from amino acid position 34 to 76, the region from amino acid position 95 to 136, and the region from amino acid position 162 to amino acid position 198 in SEQ ID NO: 2.
  • This invention also provides the use of ISLP proteins, as defined herein, for controlling or killing pests, such as insects, such as by sowing seeds or planting plants expressing an ISLP protein in a field, or by applying ISLP proteins on plants or animals to protect them from pests, such as insects. Also processes for improving yield or enhancing crop productivity are provided, which comprise the step of growing a crop comprising a DNA encoding an ISLP protein of the invention.
  • a process for isolating ISLP proteins from bacilli is provided.
  • the bacilli are grown without, or without too many, subcultivation steps before isolating ISLP proteins, since prolonged subcultivation can decrease the production of ISLP proteins.
  • the bacilli from which ISLPs are to be isolated can be grown in a susceptible pest, preferably insect pest, e.g., by applying them in their digestive system or hemolymph.
  • the ISLP proteins produced by the bacilli can then be isolated from the pest, such as an insect, e.g., from its gut or hemolymph, preferably from those pests or insects that died or showed severe growth inhibition after application of ISLP-producing bacteria.
  • bacteria producing highly toxic ISLPs for a certain target pest will easily be identified by their obvious effects on that target pest.
  • a preferred target pest and an in vivo target pest environment can induce higher levels of ISLP proteins.
  • ISLP proteins can be isolated from the bacteria, such as from culture supernatant, particularly in sporulating cultures, after centrifugation, or like Cry proteins of Bacillus thuringiensis are typically enriched and isolated.
  • the term "bacilli" refers to rod-shaped bacteria. These include bacteria of the Bacilli, Bacillales or Bacillaceae, such as bacteria of the Bacillus cereus group or bacteria of the genus Bacillus, e.g., Bacillus thuringiensis.
  • a process for isolating novel pesticidal, preferably insecticidal, ISLP proteins, particularly ISLP proteins toxic to Lepidopteran or Coleopteran insects comprises the step of screening pesticidal, preferably insecticidal, bacilli, preferably Bt, cultures for genes with high sequence similarity to ISLPs, particularly in pesticidal, e.g., insecticidal, bacilli strains, preferably Bt strains, negative for Cry or VIP genes in PCR analysis, particularly in strains showing specific toxicity to some pests, preferably insects, but not to others.
  • Such genes with high sequence similarity will be recognized using PCR technology and ISLP-specific primers, such as primers directed to the S-layer homology regions of ISLP proteins, e.g., the S-layer homology regions of ISLP1.
  • the corresponding gene can then be isolated and the new ISLP protein produced by recombinant expression technology.
  • “kDa”, as used herein, refers to the size in kiloDalton of the molecular weight of a protein.
  • “kDa”, as used herein with the term about, or referring to an approximate number (“about 80 kDa”) refers to the molecular weight observed in standard SDS- PAGE/Western blotting of a protein when compared with molecular weight standards.
  • S DS-PAG E/Westem blotting is carried using standard technology.
  • the protein or protein fragment is confirmed as an ISLP protein by means of immunological cross-reaction (e.g., Western blotting) or by its characteristics (e.g., protein characteristics typical to S-layer proteins or fragments thereof).
  • S-layer protein refers to a protein secreted from the cell producing it and capable of forming a crystalline array or lattice on the surface of prokaryotes, particularly bacteria. Such lattice is mostly formed by self-assembly of protein subunits on the surface of the prokaryote so that planar, crystalline layers are formed. Examples are the S-layer proteins described by Luckevich and Beveridge (1989), Sleytr and Beveridge (1999), and Mesnage et al. (2001), particularly the S-layer protein of Bt strain CTC, GenBank accession number AAR23791.
  • an ISLP protein refers to any protein comprising the smallest toxic fragment of the amino acid sequence of SEQ ID NO: 2 that retains insecticidal activity (hereinafter referred to as the "smallest ISLP1 toxic fragment"), particularly any insecticidal protein comprising the amino acid sequence of SEQ ID NO:2 from an amino acid between amino acid position 1 and amino acid position 31 to amino acid position 863, or any insecticidal protein comprising the amino acid sequence of SEQ ID NO:2 from an amino acid between amino acid position 1 and amino acid position 531 to amino acid position 863, or any insecticidal protein comprising the amino acid sequence of the insecticidal protease-digestion, particularly trypsin-digestion, fragment from the protein of SEQ ID NO: 2, particularly an about 30, about 40, about 50 or about 60 kDa protein obtained by trypsin-digestion from the mature protein of SEQ ID NO:2.
  • ISLP1 protein a fusion of the ISLP1 protein with a plant signal peptide, such as a chloroplast transit peptide, to make a fusion protein.
  • a plant signal peptide such as a chloroplast transit peptide
  • an insecticidal proteolytic fragment preferably a trypsin-digestion fragment, of the protein of SEQ ID NO. 2, or any insecticidally-effective fragment of the protein of SEQ ID NO. 2, as well as variants or equivalents thereof which have some amino acids deleted, added or replaced while still retaining all or most of the insecticidal activity of the ISLP1 protein.
  • a mature ISLP protein lacking its signal peptide, or having the signal peptide replaced by a Methionine or by a Met-Ala or Met- Asp dipeptide.
  • variants of the amino acid sequence in SEQ ID NO: 2 such as amino acid sequences essentially similar to SEQ ID NO: 2, having a sequence identity of at least 70%, or at least 75%, 80%, 85%, 90%, 95%, 97%, 98% or 99% at the amino acid sequence level.
  • sequence identity may be determined using pairwise alignments using the GAP program of the Wisconsin package of GCG (Madison, Wisconsin, USA, version 10.2).
  • lnsecticidal proteins according to the present invention may have some amino acids added, replaced or deleted without significantly changing, or without decreasing, the insecticidal activity of the protein.
  • the term "comprising" is to be interpreted as specifying the presence of the stated features, integers, steps or components as referred to, but does not preclude the presence or addition of one or more features, integers, steps or components, or groups thereof.
  • DNA or protein "comprising the sequence or region X" refers to a DNA or protein including or containing at least the sequence or region X, so that other nucleotide or amino acid sequences can be included at the 5' (or N-terminal) and/or 3' (or C-terminal) end.
  • a nucleotide sequence may comprise the nucleotide sequence encoding a transit peptide, and/or a 5' or 3' leader sequence.
  • a "toxic fragment" of an ISLP protein is a fragment or portion of an ISLP protein that retains some or all, preferably most, of the toxicity of the pesticidal, preferably insecticidal, mature ISLP protein.
  • a toxic fragment is obtained by cleavage of the signal peptide or by enzymatic digestion of the full length or mature ISLP protein, e.g., by digestion with pest, preferably insect, gut enzymes such as trypsin, chymotrypsin, or other proteases active in a target pest's digestive system, such as the target insect midgut digestive enzymes.
  • a toxic fragment of the ISLP1 protein of this invention is a trypsin- digestion fragment of about 50 kDa.
  • the "smallest toxic fragment" of an ISLP protein is the smallest toxic fragment of the ISLP protein.
  • Such smallest toxic fragment can be obtained by enzymatic cleavage or by expression of islp DNA with nucleotide deletions.
  • DNA encoding toxic ISLP fragments may also be synthesized chemically; thus, toxic fragments obtainable from transcription and translation of synthetic DNA is included in the definition of toxic fragment.
  • Any protein comprising the smallest ISLP toxic fragment is useful in this invention, and not only the original or mature ISLP protein, since amino acid sequences not necessary for toxicity can be deleted or can be replaced by other sequences while retaining the characteristics of the ISLP protein.
  • Toxic fragments of ISLP proteins can also be obtained by the breakdown and solubilization of ISLP proteins at the time of autolysis of the bacteria, e.g., in a pest digestive system, such as an insect midgut, or upon sporulation in in vitro cultures. Smaller, more soluble, fragments which still are immunologically detected with anti-
  • ISLP antibodies appear and can be identified or isolated after autolysis using routine technologies such as antibody-mediated purification.
  • a "target pest”, as used herein, is a pest, preferably insect, which can be killed or negatively affected (e.g., its growth is inhibited) by an ISLP.
  • This pest or insect shows toxicity above control levels, when infected or fed with bacteria producing this ISLP protein, or when fed with diet containing isolated ISLP protein.
  • Possible Lepidopteran target insects for ISLP proteins of the invention include, but are not limited to, corn earworm (Helicoverpa zea), cotton bollworm (Helicoverpa armigera), native budworm (Helicoverpa punctigera), tobacco budworm (Heliothis virescens), European corn borer (Ost ⁇ nia nubilalis), fall armyworm (Spodoptera frugiperda), black cutworm (Agrotis ipsilon), pink bollworm [Pectinophora gossypiella), yellow stem borer (Scirphophaga incertulas), leaffolder (Cnaphalocrocis medinalis), pink stem borer [Sesamia inferens), corn spotted stem borer (CMo partellus), velvet caterpillar (Anticarsia gemmatalis), soybean looper (Pseudoplusia includens), pod borer (Epinotia aporema), and Ra
  • Other possible target insects for the ISLP proteins of the invention are selected from the list consisting of: Plathypena scabra, Spodoptera exigua, Spodoptera ornithogalli, Chilo suppressalis, Hereitogramma licarisalis, Naranga aenescens, Mycalesis gotama, Marasmia patnalis, Marasmia exigua, Marasmia ruralis, Nymph ula depunctalis, Scirpophaga innotata, Spodoptera litura, Chilo polychrysus, Rupela albinella, Diatraea saccharalis, Spodoptera frugiperda, Mythimna unipuncta, Chilo zacconius and Parnara guttata, Agelastica alni, Hypera postica, Hypera brunneipennis, Haltica tombacina, Anthonomus grandis, Tenebrio molitor, Tribole
  • ISLP DNA refers to any DNA encoding an ISLP protein, such as a DNA encoding the "1SLP1 protein” as defined above, e.g., the islpi DNA shown in SEQ ID NO: 1 , particularly from nucleotide position 325 to nucleotide position 2913, preferably from nucleotide position 412 to nucleotide position 2913.
  • DNA sequences encoding insecticidal proteins which are similar enough to a DNA encoding an ISLP protein of the invention that they can (i.e., have the ability to) hybridize to these DNA sequences under stringent hybridization conditions.
  • any promoters of islp genes isolated in accordance with this invention and their use e.g., the promoter region of the islpi DNA of SEQ ID NO: 1 , which can provide powerful promoters for bacterial expression.
  • the promoter of the islpi DNA as used herein comprises the sequence of SEQ ID NO:1 from nucleotide position 1 to nucleotide position 324.
  • “Stringent hybridization conditions”, as used herein, refers particularly to the following conditions: immobilizing the relevant DNA on a filter, and prehybridizing the filters for either 1 to 2 hours in 50% formamide, 5% SSPE, 2x Denhardt's reagent and 0.1% SDS at 42° C, or 1 to 2 hours in 6x SSC, 2x Denhardt's reagent and 0.1% SDS at 68°C.
  • the denatured (Digoxigenin- or radio-) labeled probe is then added directly to the prehybridization fluid and incubation is carried out for 16 to 24 hours at the appropriate temperature mentioned above.
  • variants can be detected and isolated from bacterial strains, e.g., bacilli, particularly Bacillus spp., by hybridization as described supra, and/or by PCR technology, as known in the art.
  • Specific or degenerate primers can be made to regions of the islp DNA sequences, and used to amplify variants from known or novel bacterial strains.
  • Variants of the islp DNA of the invention include DNA sequences encoding the ISLP protein variants described above, or a DNA sequence, encoding an insecticidal protein, with at least 60%, at least 65%, at least 70%, 80% or 90%, sequence identity to an islp DNA of the invention, e.g. SEQ ID NO: 1 , preferably from nucleotide position 412 to nucleotide position 2913.
  • sequence identities referred to are calculated using the GAP program of the Wisconsin package of GCG (Madison, Wisconsin, USA) Version 10.2.
  • the GAP program is used with the following parameters for nucleic acids: the "nwsgapdna” scoring matrix, a “gap creation penalty” (or “gap weight”) of 50 and a “gap extension penalty'"(or "length weight”) of 3. Stringent hybridization conditions are as defined above.
  • ISLP protein insecticidal activity of an ISLP protein, as used herein, means the capacity of such protein to kill insects when such protein is fed to insects, preferably by expression in a recombinant host such as a plant. It is understood that a protein has insecticidal activity if it has the capacity to kill the insect during at least one of its developmental stages, preferably the larval stage. "Insect-controlling amounts" of a protein, as used herein, refers to an amount of protein which is sufficient to limit damage on a plant, caused by insects at any stage of development (e.g., insect larvae) feeding on such plant, to commercially acceptable levels.
  • Limiting insect damage to a plant may be the result of, for example, killing the insects or inhibiting insect development, fertility or growth in such a manner that the insect inflicts less damage to a plant and plant yield is not significantly adversely affected.
  • to "control" insects means to obtain at least significant growth inhibition, developmental retardation or inhibition of fertility (above control values) of such insects when treated with the ISLP protein of the invention.
  • insects susceptible to the new ISLP proteins of the invention are contacted with this protein in insect-controlling amounts, preferably insecticidal amounts.
  • Preferred target insects for the proteins of this invention are economically damaging insect pests of corn, cotton, rice, soybean, vegetable plants, Brassica species plants, Brassica napus, cauliflower, carrot, pea, wheat, barley, rye, tomato, potato, sugarbeet, cut flowers, roses, fruit plants (apple, pear, peach, strawberry, etc.), trees (such as poplar and willow), and lettuce, particularly in Europe, Northern and Southern American countries, Asia and Australia.
  • plant encompasses whole plants as well as parts of plants, such as leaves, stems, seeds, flowers or roots.
  • Pesticidal activity of an ISLP protein refers to the activity of a protein to kill, cause disease, inhibit growth or otherwise negatively affect all or part of a plant or animal pest organism, such as certain Arthropods, nematodes, mites, aphids, flies, bacteria, viruses, fungi, etc..
  • a plant or animal pest organism as used herein, is any living organism that can cause damage to a plant or animal, including humans, by causing infections, illness or death to parts or all of the plant or animal, or otherwise inhibiting growth, disabling or negatively affecting such plant or animal, preferably these are smaller organisms such as invertebrates.
  • a vector organism capable of passing on a pest organism to a plant or animal is also considered a pest organism as used herein, e.g., pests such as mosquitoes or cockroaches.
  • the nucleic acid sequence, particularly the DNA sequence, encoding a ISLP protein of this invention can be made synthetically and can be inserted in expression vectors to produce high amounts of ISLP proteins.
  • the ISLP proteins can be used to prepare specific monoclonal or polyclonal antibodies in a conventional manner (H ⁇ fte et al., 1988; Harlow and Lane, 1988).
  • antibodies that specifically bind to the ISLP protein are provided.
  • monoclonal or polyclonal antibodies that bind to an ISLP protein or to fragments or variants thereof are provided.
  • fragments of monoclonal or polyclonal antibodies, which retain the ability to bind to the ISLP protein or fragment against which they were raised e.g., single-chain antibodies.
  • An antibody to an ISLP protein can be prepared by using the ISLP protein as an antigen in an animal (such as rabbit or mouse), using methods known in the art.
  • Suitable methods for preparing antibodies include those described in Harlow and Lane “Using Antibodies: A Laboratory Manual” (New York: Cold Spring Harbor Laboratory Press, 1998); and in Liddell and Cryer "A Practical Guide to Monoclonal Antibodies” (Wiley and Sons, 1991 ).
  • the antibodies can be used to isolate, identify, characterize or purify the ISLP protein to which it binds.
  • the antibody can be used to detect the ISLP protein in a sample, by allowing antibody and protein to form an immunocomplex, and detecting the presence of the immunocomplex, for example through ELISA or immunoblots.
  • PCR primers and/or probes and kits for detecting the ISLP DNA sequences are provided.
  • PCR primer pairs (wherein each primer is at least 15 to 25, preferably at least 18 or 20 nucleotides in length) to amplify the plant-optimized ISLP DNA of this invention from samples can be synthesized based on the sequence of the ISLP, e.g., the sequence of ISLP1, by methods known in the art (see, e.g., Dieffenbach and Dveksler (1995) PCR Primer: A Laboratory Manual, Cold Spring Harbor Laboratory Press; and McPherson at al. (2000) PCR - Basics: From Background to Bench, First Edition, Springer Verlag, Germany).
  • DNA fragments of the sequence of SEQ ID NO: 1 can be used as hybridization probes.
  • An ISLP detection kit may comprise either ISLP specific primers or ISLP specific probes, and an associated protocol to use the primers or probe to detect ISLP DNA in a sample. For example, such a detection kit may be used to determine, whether a plant has been transformed with a gene encoding an ISLP protein (or part thereof) of the invention.
  • amino acid codons can be replaced by others without changing the amino acid sequence of the protein.
  • amino acids can be substituted by other equivalent amino acids without changing, or without significantly changing the pesticidal, preferably insecticidal, activity of the protein, or at least without decreasing the pesticidal, preferably insecticidal, activity of the protein.
  • amino acid substitutions include interchanging amino acids within categories: basic (e.g. Arg, His, Lys), acidic (e.g. Asp, GIu), nonpolar (e.g. Ala, VaI, Trp, Leu, lie, Pro, Met, Phe, Trp, GIy), and polar (e.g.
  • Variants or equivalents of the DNA sequences of the invention include DNA sequences encoding an ISLP as defined herein, hybridizing to the ISLP DNA sequence of SEQ ID NO: 1 under stringent hybridization conditions.
  • variants or equivalents should encode a protein with the same or substantially the same pesticidal characteristics as the protein of this invention, while other characteristics such as heat stability or susceptibility to protease cleavage can be altered.
  • it may be preferred to have available an toxic ISLP with the same or roughly similar toxicity but with a lower heat stability or with higher pepsin sensitivity and such variants can be made by known processes for random mutagenesis and selection, or by site-directed mutation of an ISLP protein of this invention, e.g., by the introduction of pepsin cleavage sites in an ISLP protein (see, WO 02074799).
  • Variants or equivalents also include DNA sequences having a different codon usage compared to the native ISLP genes of this invention but which encode a protein with the same pesticidal activity and with the same or substantially the same amino acid sequence.
  • the ISLP DNA sequences can be codon-optimized by adapting the codon usage to that most preferred in plant genes, particularly to genes native to the plant genus or species of interest, i.e., into which expression of the ISLP protein is desired using available codon usage tables (e.g., more adapted towards expression in cotton, soybean corn or rice).
  • AT or GC nucleotides For expression in plants or other Eukaryotes, long stretches of AT or GC nucleotides (e.g., stretches of 6 or more A or T nucleotides, or stretches of 6 or more G or C nucleotides) are avoided, removed or reduced in the ISLP genes of the invention, and suitable restriction sites may be introduced.
  • the N-terminus of an ISLP protein can be modified to have an optimum translation initiation context, thereby adding or deleting one or more amino acids at the N-terminal of the protein.
  • the proteins of the invention to be expressed in plants cells start with a Met-Asp or Met-Ala dipeptide for optimal translation initiation, hence sometimes requiring the insertion in the ISLP DNA of a codon encoding an Asp or Ala amino acid downstream of the start codon as a new second codon (if such second codon is not already Ala or Asp).
  • the DNA sequences may also be modified to remove illegitimate splice sites or transcription termination signals.
  • bacterial genes may contain motifs that are recognized in other hosts, especially in eukaryotic host such as plants, as 5' or 3' splice sites or transcription termination signals, transcription in those other hosts may be ineffective or may be terminated prematurely.
  • Illegitimate splice sites or transcription termination signals can be identified by computer-based analysis of the DNA sequences and/or by PCR analysis as known in the art. Any DNA sequence differing in its codon usage but encoding the same protein or a similar protein with substantially the same pesticidal activity can be constructed, depending on the particular purpose.
  • Such alternate DNA sequences include synthetic or semisynthetic DNA sequences that have been changed in order to inactivate certain sites in the gene. This inactivation can be accomplished by, for example, adapting the overall codon usage to that of a more related host organism, such as that of the host organism in which expression is desired.
  • a more related host organism such as that of the host organism in which expression is desired.
  • codon usage modification is not critical for this invention as long as most or all of the cryptic regulatory sequences or processing elements (such as plant polyadenylation signals and splice sites) have been replaced by other sequences, and preferably the AT-content of the coding region approaches that of the host organism.
  • the phrase “substantially the same” refers to a protein whose mean LC50 value differs by no more than a factor of 2 to 5, preferably 2, from the mean LC50 value obtained for the protein compared to.
  • mean LC50 is the concentration of protein causing 50% mortality of the test population, calculated from three independent bioassays carried out using the same bioassay conditions. LC50 values are calculated with Probit analysis, using the program POLO PC (from LeOra Software, 1987, Berkely, California).
  • 95% (or 90%) confidence limits are calculated for the LC50 values of each of the two proteins to be compared in order to determine whether a statistically significant difference in LC50 values exists.
  • the toxicity of the two proteins is seen to be substantially the same, if - in the same or in a comparable experimental setup using proper controls - the confidence limits overlap and substantially different if the confidence limits do not overlap.
  • the /SLP DNA sequences of the invention, prepared from total DNA can be ligated in suitable expression vectors and transformed in a bacterial strain, such as E. coli or another bacterial strain, preferably in other bacilli such as in Bacillus thuringiensis.
  • a DNA encoding the bacterial signal peptide of the ISLP protein or a suitable other bacterial signal peptide is included in the DNA construct.
  • the clones can then be screened by conventional colony immunoprobing methods (French et al., 1986) for expression of the toxin with monoclonal or polyclonal antibodies raised against the ISLP proteins.
  • the bacterial clones can be screened for production of ISLP proteins (cell lysate or supernatant can be run on SDS-PAGE gels using standard methods and standard western-blotting procedures can be carried out), or the bacteria or purified or semi-purified ISLP protein can be tested for their pesticidal activity compared to control bacteria using methods known in the art or described herein below.
  • the clones can also be analysed for the presence of mRNA encoding ISLP protein using standard PCR procedures, such as RT-PCR.
  • the genes encoding the ISLP proteins of this invention can be sequenced in a conventional manner (Maxam and Gilbert, 1980; Sanger, 1977) to obtain the DNA sequence. Sequence comparisons indicate that islp genes are different from previously described genes encoding pesticidal, particularly insecticidal, bacterial toxins, and belong to a new class of genes encoding pesticidal or insecticidal proteins with significant sequence identity to bacterial, preferably bacilli, S-layer proteins.
  • An pesticidally-effective part of the DNA sequences encoding a pesticidally- effective portion of the newly identified ISLP proteins, can be made in a conventional manner after sequence analysis of the gene.
  • the amino acid sequence of the ISLP proteins can be determined from the sequence of the isolated DNA.
  • the phrase "a pesticidally effective part (or portion or fragment)" of a DNA sequence encoding the ISLP protein, also referred to herein as a "truncated gene" or "truncated DNA,” as used herein refers to a DNA sequence encoding a toxic fragment of an ISLP protein as defined herein.
  • suitable restriction sites can be introduced, flanking the DNA sequence. This can be done by site-directed mutagenesis, using well-known procedures (see, e.g., Stanssens et al., 1989; White et al., 1989).
  • the codon usage of the ISLP gene or pesticidally effective ISLP gene part of this invention can be modified to form an equivalent, modified or artificial gene or gene part in accordance with PCT publications WO 91/16432 and WO 93/09218 and publications EP 0 385 962, EP 0 359 472 and US 5,689,052.
  • the ISLP genes or gene parts may also be inserted in the plastid (e.g., chloroplast) or mitochondrial genome of a plant and expressed there using a suitable promoter (see, e.g., McBride et al., 1995; US 5,693,507).
  • an intron e.g., a monocot intron
  • a monocot intron can also be added to the chimeric gene.
  • the insertion of the intron of the maize AdM gene into the 5' regulatory region has been shown to enhance expression in maize (CaIMs et. al., 1987).
  • the HSP70 intron as described in US 5,859,347, may be used to enhance expression.
  • the DNA sequence of the ISLP gene or its toxic fragment can be further changed in a translationally neutral manner. Such changes may modify possibly inhibiting DNA sequences present in the gene part by means of site-directed intron insertion and/or by introducing changes to the codon usage. Changes in codon usage may be, e.g., to adapt the codon usage to that most preferred by plants, particularly the host plant, without changing, or without significantly changing, the encoded amino acid sequence.
  • the proteins may be targeted to intracellular organelles in plant cells, such as plastids (e.g., chloroplasts), mitochondria, or may be secreted from the cell.
  • the chimeric genes of the invention comprise a coding region encoding a signal or targeting peptide, preferably a plant signal or targeting peptide, linked to the ISLP protein-coding region of the invention.
  • Peptides that may be included in the proteins of this invention are the transit peptides for chloroplast or other plastid targeting, such as duplicated transit peptide regions from plant genes whose gene product is targeted to the plastids, the optimized transit peptide of Capellades et al.
  • Useful signal peptides in accordance with the invention include the chloroplast transit peptide (e.g., Van Den Broeck et al., 1985), or the optimized chloroplast transit peptide of US 5,510,471 and US 5,635,618 causing transport of the protein to the chloroplasts, a secretory signal peptide or a peptide targeting the protein to other plastids, mitochondria, the ER, or another organelle.
  • Signal sequences for targeting to intracellular organelles or for secretion outside the plant cell or to the cell wall are found in naturally targeted or secreted proteins, such as those described by Kl ⁇ sgen et al. (1989), Klosgen and Weil (1991), Neuhaus & Rogers (1998), Bih et al.
  • Alternative signal sequences include the signal peptide sequences from targeted or secreted proteins of corn, cotton, soybean or rice.
  • an appropriate secretion signal peptide may be fused to the amino terminal end (N-terminal end) of the ISLP protein.
  • any native bacterial secretion signal peptide can be deleted and replaced by the dipeptide Met-Ala or Met-Asp, or by another signal peptide, such as a plant secretion signal peptide as described above.
  • amino acids 1 to 29 of the ISLP proteins of the invention e.g., the ISLP1 protein shown in SEQ ID NO: 2, comprise a bacterial signal peptide.
  • Amino acids 1 to 29 may be removed, or may be replaced by a Methionine amino acid or by a Met-Ala or Met- Asp dipeptide, or may be replaced by an appropriate signal peptide, such as a plant signal peptide as described above.
  • Signal peptides can be detected using computer based analysis, using programs such as the program Signal Peptide search (SignalP V1.1 or 2.0), using an appropriate matrix (e.g., for prokaryotic gram-positive bacteria) and a threshold score of less than 0.5, a threshold score of 0.25, or less (see, e.g., Von Heijne, Gunnar, 1986 and Bendtsen et al., 2004), or by alignment with similar proteins with known signal peptides.
  • the binding properties of the ISLP proteins of the invention can be evaluated, using methods known in the art (see, e.g., Van Rie et al., 1990), to determine if the ISLP proteins of the invention bind to sites in the pest, such as the insect gut, that are not recognized (or competed for) by other bacterial proteins.
  • a novel class of insecticidal proteins binding to different binding sites in relevant susceptible insects compared to known insecticidal proteins such as Bt toxins of the Cry, Cyt or VIP toxin families is very valuable.
  • Such proteins can be used to replace known bacterial proteins to which insects may have developed resistance, or to use in combination with insecticidal bacterial proteins having a different mode of action to prevent or delay the development of insect resistance against bacterial proteins, particularly when expressed (preferably simultaneously) in a plant. Because of the characteristics of the ISLP toxins of the present invention, they are extremely useful for transforming plants, e.g., monocots such as corn and rice and dicots such as cotton, vegetable crops, beans and soybean, to protect these plants from insect damage. The mode of action of the ISLP proteins of the current invention is different compared to the known Bt toxins that are currently used in transgenic plant products, such as Cry or VIP proteins of bacilli. Such binding properties can be measured by routine binding assays as described above or in US patent 6,291,156 and US patent 6,137,033.
  • an ISLP protein of this invention with another insect control protein, particularly a bacterial Cry protein, such as Cry1F, Cry2A or CryiAc protein, or a VIP or VIP-like protein, such as VIP3A, preferably a protein which does not recognise at least one binding site recognised by such ISLP protein.
  • bacterial Cry protein such as Cry1F, Cry2A or CryiAc protein
  • VIP or VIP-like protein such as VIP3A
  • Suitable insect control proteins to combine with the ISLP proteins of this invention include, but are not limited to, the Cry proteins, such as a Cry1 B, Cry1C, Cry1 D, or Cry1 E protein or toxic fragments thereof, a protein comprising the Cry1 F toxic fragment or hybrids derived from a Cry1 F protein (e.g., the hybrid Cry1A-Cry1F proteins described in US 6,326,169; US 6,281 ,016; US 6,218,188, or toxic fragments thereof), a protein comprising the Cry1A- type proteins or toxic fragments thereof, preferably the Cry 1Ac protein or hybrids derived from the CryiAc protein (e.g., the hybrid Cry1Ab-Cry1Ac protein described in US 5,880,275) or a protein comprising the CrylAb protein or insecticidal fragments thereof as described in EP4518
  • the Cry proteins such as a Cry1 B, Cry1C, Cry1 D, or Cry1
  • such co-expression is easily obtained by transforming a plant already expressing an insect control protein with a DNA encoding an ISLP protein of this invention, or by crossing plants transformed with a known insect control protein with plants transformed with one or more ISLP proteins of this invention.
  • the ISLP protein may be used as first insect control protein and as second insect control protein the CrylAb, CryiAc, Cry2Ae or VIP3Aa proteins or proteins comprising their toxic fragments, hybrids or variants thereof can be used.
  • Methods for obtaining expression of different insecticidal proteins in the same plant in an effort to minimize or prevent resistance development to transgenic insect-resistant plants are described in EP 0 408 403.
  • the different proteins can be expressed in the same plant, or each can be expressed in a single plant and then combined in the same plant by crossing the single plants with one another.
  • each parent plant can express a single protein. Upon crossing the parent plants to produce hybrids, both proteins are combined in the hybrid plant.
  • the different toxin genes may be inserted at the same place or genetic locus of a plant, so that the genes will not segregate in the progeny of that plant.
  • Bt Cry proteins are expressed as protoxins, which are converted into the toxic core by proteolysis in the insect gut.
  • cry genes encoding either the full protoxin or the toxic core or any intermediate form may be used.
  • the transgenic plants of the invention may also be transformed with a DNA encoding a protein conferring resistance to a broad-spectrum herbicide, e.g., herbicides based on glufosinate or glyphosate.
  • a broad-spectrum herbicide e.g., herbicides based on glufosinate or glyphosate.
  • the pesticidally effective ISLP gene part or its equivalent, preferably the ISLP chimeric gene, encoding a pesticidally effective portion of the ISLP protein can be stably inserted in a conventional manner into the nuclear genome of a single plant cell, and the so-transformed plant cell can be used in a conventional manner to produce a transformed plant that controls pests, such as insect pests.
  • a T-DNA vector containing a DNA encoding an ISLP protein, in Agrobacterium tumefaciens can be used to transform the plant cell. Thereafter, a transformed plant can be regenerated from the transformed plant cell using the procedures described, for example, in EP 0 116 718, EP 0 270 822, PCT publication WO 84/02913 and published European Patent application EPO 242 246 and in Gould et al. (1991 ).
  • the construction of a T-DNA vector for Agrobacterium-mediate ⁇ plant transformation is well known in the art.
  • the T-DNA vector may be either a binary vector as described in EP 0 120 561 and EP 0 120 515 or a co-integrate vector which can integrate into the Agrobacterium Ti-plasmid by homologous recombination, as described in EP 0 116 718.
  • Preferred T-DNA vectors each contain a promoter operably linked to the pesticidally effective ISLP gene part between T-DNA border sequences, or at least located to the left of the right border sequence. Border sequences are described in Gielen et al. (1984).
  • vectors can be used to transform the plant cell, using procedures such as direct gene transfer (as described, for example in EP 0 223 247), pollen mediated transformation (as described, for example in EP 0 270 356 and WO 85/01856), protoplast transformation as, for example, described in US 4,684,611 , plant RNA virus-mediated transformation (as described, for example in EP 0 067 553 and US 4,407,956), liposome-mediated transformation (as described, for example in US 4,536,475), and other methods, such as the recently described methods for transforming certain lines of corn (e.g., US 6,140,553; Fromm et al., 1990; Gordon- Kamm et al., 1990) and rice (Shimamoto et al., 1989; Datta et al.
  • direct gene transfer as described, for example in EP 0 223 247)
  • pollen mediated transformation as described, for example in EP 0 270 356 and WO 85/01856
  • Cotton refers to Gossypium spp., particularly G. hirsutum and G. barbadense.
  • rice refers to Oryza spp., particularly O. sativa.
  • Soybean refers to Glycine spp, particularly G. max.
  • Vegetable plants or vegetables refers to cucumber, tomato, lettuce, Brussels endive, Brassica vegetables such as cauliflower or cabbages, leek, lettuce, onion, (water)melon, artichoke, carrot, or peppers.
  • transformation of the nuclear genome also transformation of the plastid genome (e.g., the chloroplast genome) is included in the invention.
  • the plastid genome e.g., the chloroplast genome
  • Kota et al. (1999) have described a method to over-express a Cry2Aa protein in tobacco chloroplasts.
  • the resulting transformed plant can be used in a conventional plant breeding scheme to produce more transformed plants with the same characteristics or to introduce the pesticidally effective ISLP gene part into other varieties of the same or related plant species.
  • Seeds, which are obtained from the transformed plants, contain the gene encoding the ISLP protein as a stable genomic insert.
  • Cells of the transformed plant can be cultured in a conventional manner to produce the pesticidally effective portion of the ISLP toxin or protein, which can be recovered for use in conventional insecticide compositions, particularly insecticide compositions against Lepidoptera.
  • the pesticidally effective ISLP gene part is inserted in a plant cell genome so that the inserted gene is downstream ⁇ i.e., 3') of, and under the control of, a promoter which can direct the expression of the gene part in the plant cell. This may be accomplished by inserting the ISLP chimeric gene in the plant cell genome, for example in the nuclear or plastid ⁇ e.g., chloroplast) genome.
  • Suitable promoters include, but are not limited to: the strong constitutive 35S promoters (the "35S promoters") of the cauliflower mosaic virus (CaMV) of isolates CM 1841 (Gardner et al., 1981 ), CabbB-S (Franck et al., 1980) and CabbB-JI (Hull and Howell, 1987); the 35S promoter described by Odell et al.
  • the 35S promoters the strong constitutive 35S promoters of the cauliflower mosaic virus (CaMV) of isolates CM 1841 (Gardner et al., 1981 ), CabbB-S (Franck et al., 1980) and CabbB-JI (Hull and Howell, 1987); the 35S promoter described by Odell et al.
  • promoters from the ubiquitin family e.g., the maize ubiquitin promoter of Christensen et al., 1992, EP 0 342 926, see also Cornejo et al., 1993
  • the gos2 promoter de Pater et al., 1992
  • the emu promoter Last et al., 1990
  • Arabidopsis actin promoters such as the promoter described by An et al. (1996)
  • rice actin promoters such as the promoter described by Zhang et al. (1991) and the promoter described in US 5,641 ,876
  • promoters of the Cassava vein mosaic virus WO 97/48819, Verdaguer et al.
  • a promoter can be utilized which is not constitutive but rather is specific for one or more tissues or organs of the plant (e.g., leaves and/or roots) whereby the inserted ISLP gene part is expressed only in cells of the specific tissue(s) or organ(s).
  • an insecticidally effective ISLP gene part could be selectively expressed in the leaves of a plant (e.g., corn, cotton, rice, soybean) by placing the insecticidally effective gene part under the control of a light-inducible promoter such as the promoter of the ribulose-1 ,5-bisphosphate carboxylase small subunit gene of the plant itself or of another plant, such as pea, as disclosed in US 5,254,799.
  • the promoter can, for example, be chosen so that the ISLP gene of the invention is only expressed in those tissues or cells on which the target pest, such as an insect pest, feeds so that feeding by the susceptible target pest will result in reduced damage to the host plant, compared to plants which do not express the ISLP gene.
  • a pest mainly damaging the roots can thus effectively be controlled by expressing an ISLP gene under a root specific promoter.
  • a promoter preferentially active in roots is described in WO00/29566.
  • a suitable promoter for root preferential expression is the ZRP promoter (and modifications thereof) as described in US 5,633,363.
  • a promoter whose expression is inducible for example a wound-inducible promoter such as, e.g., the MPI promoter described by Cordera et al. (1994), which is induced by wounding (such as caused by insect feeding), or a promoter inducible by a chemical, such as dexamethasone as described by Aoyama and Chua (1997) or a promoter inducible by temperature, such as the heat shock promoter described in US 5,447,858, or a promoter inducible by other external stimuli.
  • a wound-inducible promoter such as, e.g., the MPI promoter described by Cordera et al. (1994), which is induced by wounding (such as caused by insect feeding), or a promoter inducible by a chemical, such as dexamethasone as described by Aoyama and Chua (1997) or a promoter inducible by temperature, such as the heat shock promoter described in US 5,447,858, or a promoter induc
  • the Agrobacterium TR2' promoter In monocot plants, such as corn and rice, the Agrobacterium TR2' promoter, or variants thereof, are a preferred wound-induced promoter to drive transcription of a chimeric ISLP gene of the invention, see WO 03/093483.
  • the pesticidally effective ISLP gene part may be inserted into the plant genome so that the inserted gene part is upstream (i.e., 5') of suitable 3 1 end transcription regulation signals (i.e., transcript formation and polyadenylation signals). This is preferably accomplished by inserting the ISLP chimeric gene in the plant cell genome.
  • Suitable polyadenylation and transcript formation signals include those of the CaMV 35S gene, the nopaline synthase gene (Depicker et al., 1982), the octopine synthase gene (Gielen et al., 1984) and the T-DNA gene 7 (Velten and Schell, 1985), which act as 3'-untranslated DNA sequences in transformed plant cells.
  • Introduction of the T-DNA vector into Agrobacterium can be carried out using known methods, such as electroporation or triparental mating.
  • the pesticidally-effective ISLP gene part can optionally be inserted in the plant genome as a hybrid gene (US 5,254,799; Vaeck et al., 1987) under the control of the same promoter as a selectable or scorable marker gene, such as the neo gene (EP 0 242 236) encoding kanamycin resistance, so that the plant expresses a fusion protein that is easily detectable.
  • a hybrid gene US 5,254,799; Vaeck et al., 1987
  • a selectable or scorable marker gene such as the neo gene (EP 0 242 236) encoding kanamycin resistance
  • Transformation of plant cells can also be used to produce the proteins of the invention in large amounts in plant cell cultures, e.g., to produce an ISLP protein that can then be applied onto crops after proper formulation.
  • a transgenic plant cell refers to a plant cell (or also a plant protoplast) as such in isolation or in tissue culture, or to a plant cell (or protoplast) contained in a plant or in a differentiated organ or tissue, and both possibilities are specifically included herein.
  • a reference to a plant cell in the description or claims is meant to refer not only to isolated cells in culture, but also to any plant cell, wherever it may be located or in whatever type of plant tissue or organ it may be present.
  • All or part of an ISLP gene, encoding an insecticidal, particularly anti-Lepidopteran, protein, can also be used to transform other microorganisms, including bacteria, such as a B. thuringiensis, which may already have insecticidal activity against Lepidoptera or Coleoptera. Thereby, a transformed Bt strain can be produced which is useful for combating a wide spectrum of Lepidopteran and/or Coleopteran insect pests or for combating additional Lepidopteran insect pests.
  • Transformation of bacteria such as bacteria of the genus Pseudomonas, Agrobacterium, Bacillus or Escherichia, with all or part of the ISLP gene of this invention, incorporated in a suitable cloning vehicle, can be carried out in a conventional manner, using, e.g., conventional electroporation techniques as described in Mahillon et al. (1989) and in PCT Patent publication WO 90/06999.
  • Transformed Bacillus species strains containing the ISLP gene of this invention can be fermented by conventional methods (Dulmage, 1981; Bernhard and Utz, 1993) to provide high yields of cells. Under appropriate growth conditions, these strains can produce ISLP protein in high yields.
  • ISLP genes are fungi, algae, or viruses, particularly species which are plant colonizing (e.g., (endo)symbiontic) species or pathogens of pests, such insect pests.
  • An insecticidal, particularly anti-Lepidopteran, composition of this invention can be formulated in a conventional manner using the microorganisms transformed with the ISLP gene, or an ISLP protein, or an insecticidafly effective ISLP portion as an active ingredient, together with suitable carriers, diluents, emulsifiers and/or dispersants (e.g., as described by Bernhard and Utz, 1993).
  • This insecticide composition can be formulated as a wettable powder, pellets, granules or dust or as a liquid formulation with aqueous or non-aqueous solvents as a foam, gel, suspension, concentrate, etc..
  • aqueous or non-aqueous solvents as a foam, gel, suspension, concentrate, etc.
  • a method for controlling insects, particularly Lepidoptera or Coleoptera, in accordance with this invention can comprise applying (e.g., spraying), to a locus (area) to be protected, an insecticidal amount of the ISLP proteins or compositions comprising the ISLP proteins or comprising host cells transformed with the ISLP genes of this invention.
  • the locus to be protected can include, for example, the habitat of the insect pests or growing vegetation (e.g. application to the foliage) or an area where vegetation is to be grown (e.g. application to soil or water).
  • a composition according to the present invention comprises an insecticidal amount of at least one of the ISLP proteins of the invention, which may be produced by a bacterial host. Such a composition may be applied to leaves, soil, or seed coating.
  • contacting is used herein to mean, “to bring into physical contact with.”
  • Contacting a plant with an insecticidal protein means that the insecticidal protein is brought into contact with cells of the plant, either internally (for example by expression in the plant) or externally (for example by applying compositions comprising the insecticidal protein externally to the plant). It is understood that the term does not indicate the length of time of contact, but comprises any period of contact.
  • the contact may be long enough and extensive enough (with a high enough amount of protein contacting a large enough number of cells) to prevent or reduce insect damage.
  • This invention further relates to a method for controlling Lepidopteran or Coleopteran cotton pests or sucking insect pests of cotton, such as boll weevils, bollworms, budworms, or earworms, Aphis gossypii, Myzus persicae, Lygus bugs, whitefly, stink bugs, thrips, or Creontiades dilutus.
  • Specific Lepidopteran cotton pests that may be controlled by the methods of the present invention include, but are not limited to, those selected from the group of Helicoverpa zea (Corn Earworm), Helicoverpa armigera (Cotton Bollworm), Helicoverpa punctigera (Native Bollworm), Heliothis virescens (Tobacco Budworm), Spodoptera frugiperda (Fall Armyworm) and Pectinophora gossypiella (Pink Bollworm).
  • the method of controlling cotton insect pests comprises applying to an area or plant to be protected, an ISLP protein as defined herein.
  • the invention also relates to the use of the ISLP proteins of this invention, against Lepidopteran, aphid or Coleopteran cotton insect pests to minimize damage to cotton plants.
  • a target insect pest for the ISLP proteins of this invention, such as the ISLP1 protein can also be Epilachna varivestis, the Mexican bean beetle.
  • This invention further relates to a method for controlling Lepidopteran or
  • Coleopteran maize pests or aphids such as corn leaf aphids (Rhopalosiphum maidis), greenbugs (Schizaphis graminum) or green peach aphids (Myzus persicae); earworms, armyworms, cutworms, stalkborers, wireworms, corn borers or corn rootworms.
  • Specific maize pests that may be controlled by the methods of the present invention may be selected from the group of Helicoverpa zea (Corn Earworm), Agrotis ipsilon (Black Cutworm), Ostrinia nubilalis (European Corn Borer), Diabrotica spp. corn rootworms and Spodoptera frugiperda (Fall Armyworm).
  • the method comprises applying to an area or plant to be protected, an ISLP protein as defined herein, as defined herein. This may be accomplished by contacting a maize plant with an ISLP protein of this invention, for example by planting a maize plant transformed with an ISLP gene of this invention, or spraying a composition containing an ISLP protein of this invention.
  • the invention also relates to the use of the ISLP proteins of this invention, against Lepidopteran maize insect pests to minimize damage to maize plants. This invention further relates to a method for controlling Lepidopteran or
  • Coleopteran rice pests or sucking insects on rice such as rice leafhoppers or planthoppers, rice (black) bugs, rice stemborers, rice skippers, rice cutworms, rice armyworms, rice caseworms, and rice leaffolders or white grubs.
  • Specific Lepidopteran rice insect pests that may be controlled by the methods of the present invention may be selected from the group of Yellow Stem Borer ⁇ Scirphophaga incertulas), Leaffolder (Cnaphalocrocis medinalis), Pink Stem Borer (Sesamia inferens) and Corn Spotted Stem Borer (CMo partellus).
  • the method comprises applying to an area or plant to be protected, an ISLP protein as defined herein.
  • the invention also relates to the use of the ISLP proteins of this invention, against Lepidopteran, aphid or Coleopteran rice insect pests to minimize damage to rice plants.
  • This invention further relates to a method for controlling Lepidopteran, aphid or Coleopteran soybean pests.
  • Specific soybean pests that may be controlled by the methods of the present invention may be selected from the group of Velvet Bean Caterpillar (Anticarsia gemmatalis), Soybean Looper (Pseudoplusia includens), Beet Armyworm (Spodoptera exigua), Yellowstriped Armyworm (Spodoptera ornithogalli), Corn Earworm (Helicoverpa zea), Pod Borer (Epinotia aporema) and Rachiplusia nu.
  • This method comprises applying to an area or plant to be protected, an ISLP protein as defined herein.
  • This may be accomplished by contacting a soybean plant with an ISLP protein, e.g. an ISLP1 protein, of this invention, for example by planting a soybean plant transformed with an ISLP gene of this invention, or spraying a composition containing an ISLP protein of this invention.
  • an ISLP protein e.g. an ISLP1 protein
  • the invention also relates to the use of the ISLP proteins of this invention, against Lepidopteran soybean insect pests to minimize damage to soybean plants.
  • cells of the recombinant hosts expressing the ISLP protein can be grown in a conventional manner on a suitable culture medium.
  • the produced ISLP protein can be separated and purified from lysed cells, or when secreted, from the growth medium. If the proteins are not secreted, the cells can be lysed using conventional means such as enzyme degradation, by sonication or by using detergents or the like.
  • the ISLP protein can then be separated and purified by standard techniques such as chromatography, extraction, electrophoresis, or the like.
  • RNA RNA molecule
  • suitable regulatory regions e.g., a plant- expressible promoter.
  • a gene may thus comprise several operably linked fragments such as a promoter, a 5' leader sequence, a coding region, and a 3' nontranslated sequence, comprising a polyadenylation site.
  • a gene endogenous to a particular organism is a gene, which is naturally found in that organism in nature.
  • a "chimeric gene,” when referring to an ISLP DNA of this invention, refers to an ISLP DNA sequence having 5' and/or 3' regulatory sequences different from the naturally-occurring bacterial 5' and/or 3' regulatory sequences, which drive the expression of the ISLP gene in its native host cell.
  • expression of a gene when referring to the ISLP genes of the invention, refers to the process wherein a DNA coding region which is operably linked to appropriate regulatory regions, such as to a promoter, is transcribed and translated into a protein.
  • sequence identity refers to the number of positions in the two optimally aligned sequences which have identical residues (x100) divided by the number of positions compared.
  • a gap i.e., a position in an alignment where a residue is present in one sequence but not in the other is regarded as a position with non-identical residues (for sequences of different length the size is equaled to that the shortest sequence, e.g., in the case of the alignment of a fragment of an ISLP and a full length S-layer protein, the comparison is with respect to the corresponding part of the same size in the S-layer protein).
  • the GAP program which uses the Needleman and Wunsch algorithm (1970) and which is provided by the Wisconsin Package, Version 10.2, Genetics Computer Group (GCG), 575 Science Drive, Madison, Wisconsin 53711 , USA, may be used.
  • GAP uses the Needleman and Wunsch global alignment algorithm to align two sequences over their entire length, maximizing the number of matches and minimizes the number of gaps.
  • the default scoring matrix used is "nwsgapdna” and for proteins the default scoring matrix is "blosum62" (Henikoff & Henikoff, 1992).
  • the percentage sequence similarity can be obtained in such alignments using standard software, which indicates not only the percentage of identical residues but also includes residues which differ but are of similar nature (such as differences in conservative amino acids, as defined herein, for protein alignments). Examples of algorithms that are suitable for determining percent sequence identity and sequence similarity are the BLAST and BLAST 2.0 algorithms, which are described in
  • SEQ ID NO: 1 DNA coding sequence and amino acid sequence of the islpi gene
  • SEQ ID NO: 2 amino acid sequence of the ISLP1 protein
  • SEQ ID NO: 3 PCR primer ISLPIXder
  • SEQ ID NO: 4 PCR primer ISLPIXrev
  • SEQ ID NO: 5 PCR primer BSLX-1
  • SEQ ID NO: 6 PCR primer BSLX-4
  • SEQ ID NO: 7 PCR primer BSLX-3
  • SEQ ID NO: 8 PCR primer BSLX-2
  • SEQ ID NO: 9 PCR primer BSLN-5
  • SEQ ID NO: 10 PCR primer BSLN-6
  • SEQ ID NO: 12 PCR primer BSLP-7
  • SEQ ID NO: 13 PCR primer EAGB-4
  • SEQ ID NO: 14 amino acid sequence of the N-terminus of the isolated mature ISLP1 protein
  • SEQ ID NO:15 amino acid sequence of the N-terminus of the about 50 kDa tryptic fragment of the ISLP1 protein Unless stated otherwise in the Examples, all recombinant DNA techniques are carried out according to standard protocols as described in Sambrook and Russell
  • Bacterial strains Bacillus thuringiensis (Bt) strains were isolated from dead insect (Epilachna varivestis) samples by the acetate selection method (Travers et al., 1987). The E. varivestis dead bodies were washed twice with sodium hypochlorite 1% and with sterile water before homogenization and Bt strain isolation. Bioassays. The bioassays against E. varivestis were performed with spore/crystal suspensions using the leaf-dip technique. Plant leaves of Phaseolus vulgaris were dipped in toxin dilution and allowed to dry. Different protein concentrations were tested with five larvae of the first instar per treated leaf. Four repetitions were done per concentration.
  • Bioassays against first instar larvae of Manduca sexta or Spodoptera frugiperda were done in artificial diet as previously described (Bravo et al., 1998).
  • Bioassays against Aedes aegypti mosquitoe larvae were done in 100 ml H2O as described by Ibarra et al. (2003).
  • the ISLP1 strain was grown in Petri dishes containing solid nutrient broth sporulation medium (Lereclus et al., 1995). The spore/crystal mixture was collected in 5 ml sterile water. Centrifuged 10 min at 10,000 rpm, the supernatant was recovered and the pellet containing only spores was discarded. This step was repeated 5 times in order to eliminate all spores from the suspension. Finally the crystal inclusions were recovered by centrifugation for 30 min at 19,000 rpm.
  • the crystal proteins were solubilized in 50 mM Na2CO3, pH 10.5 0.2% beta-mercaptoethanol and purified by anion exchange chromatography in a Q-sepharose column FPLC Pharmacia (Hill, 1983).
  • N-Terminal sequencing N-terminal sequencing of the protein produced by the ISLP1 strain was performed at the Harvard Microchemistry Facility of Harvard University (Cambridge, Massachusetts) after SDS-PAGE 7 % and transfer onto polyvinylidene difluoride membranes (Miliipore Co., Bedford, MA) in a semidry transfer chamber as directed by the manufacturer. The N-terminal sequence was also done from a trypsin fragment of the ISLP1 crystal protein that was purified by HPLC size exclusion chromatography (G ⁇ ereca and Bravo, 1999).
  • ISLPIXrev ACGCTCTAGATCGCCGTATTGGTCAGTTGTTAC, SEQ ID NO.4
  • PCR reactions were performed by standard techniques (Sambrook et al., 1989) with Pfu DNA polymerase (Stratagene La JoIIa, CA) because of its high fidelity.
  • Total DNA was extracted from ISLP1 strain (Msadek et al., 1990) and used as template in all PCR reactions.
  • the PCR product was used for Blast analysis and two related sequences of S-layer genes were obtained (accession number u38842 and x99724). Alignment of these sequences demonstrated that they shared similar 5' and 3' ends.
  • PCR primers were designed from 5' and 3' terminal ends of these S-layer genes and from the internal sequence of the ISLP1 -amplified fragment.
  • Primers BSLX-1 GCTCTAGATGAGAGTGCTTTATAGGAAAAT, SEQ ID NO: 5
  • BSLX-4 GCTCTAGATCTTCAGCCGGAGCGTATGTACC, SEQ ID NO: 6
  • primers BSLX-3 GCTCTAGATACTGCTGAGGCTGCTGGTGAGG, SEQ ID NO: 7
  • BSLX-2 GCTCTAGATCCTCGACCTGCTTCACTATCA, SEQ ID NO: 8 amplify a 1372 bp 3' fragment.
  • PCR fragment was digested with Xba1 (New England BioLabs, Beverly, MA) and cloned into pBluescript SK (Stratagene, La JoIIa, CA) previously digested with Xba1.
  • the ligation products were purified by extraction with phenol/chloroform, precipitated with ethanol and electroporated into TG 1 Escherichia coli electrocompetent cells (Lereclus et al., 1989).
  • Transformant colonies were grown on LB agar plates, supplemented with ampicillin (100 Dg/ml), colonies were mixed with glycerol (20%) and stored at -7O 0 C.
  • ISLP1-SL1 plasmids named ISLP1-SL1 , ISLP1-SL2 and ISLP1-SL3 and their DNA inserts were sequenced using automatic DNA sequencing facilities. Cloning and expression of ISLP1 protein in S. thu ⁇ ngiensis. The complete /s/p1 gene was reconstituted by cloning three PCR fragments into plasmid pHT315 (Lereclus et al., 1989). The first PCR product containing the promotor region was obtained with primers BSLX-1 and BSLN-5
  • Primer BSLX-1 has an extra 10 bp at the 5'end containing a Xba1 restriction site and primer BSLN-5 has an internal Nco1 restriction site.
  • the second PCR fragment was obtained with primer BSLN-6 (TTATACCATGGCAAAGACTAACTCTTAC, SEQ ID NO: 10) that contains an internal Nco1 restriction site and primer BSLP-8
  • the DNA fragments contained in these plasmids were purified, ligated and inserted into plasmid pHT315 previously digested with Xbal and BamHI.
  • the product of the ligation reaction was directly transformed in the acrystalliferous Bacillus thuringiensis strain 407 (Lereclus et al., 1989) that was kindly provided by Dr. Didier Lereclus (Pasteur Institute, France) and was grown at 30 0 C in LB supplemented with 7.5 Dg/ml erythromycin.
  • the resulting plasmid was named pHT-ISLP1.
  • the Bt strain containing pHT-ISLP1 was grown in Petri dishes containing solid HCT medium supplemented with erythromycin.
  • the spore/crystal mixture was collected in 2 ml sterile water and used in Western blot experiments. Detection was done with anti-SL-ISLP1 polyclonal antibody (1/10,000; 1 h) and visualized with a goat anti-rabbit antibody coupled with horseradish peroxidase (HR) (Sigma, St. Louis, MO) (1/7,500; 1 h), followed by SuperSignal chemiluminescent substrate (Pierce, Rockford, II) as described by the manufacturer.
  • HR horseradish peroxidase
  • the ISLP1 strain, the Bt strain containing pHT-ISLP1 and the acrystalliferous Bt strain 407 were grown in BHI (Difco) broth medium until 0.9 O. D. at 600 nm in order to have exclusively vegetative cells. Cells were pelleted by centrifugation (10 min at 10,000 rpm). Pellets were washed and resuspended in 1/50 of the initial volume of 1 , 1.5 or 2 M guanidinium hydrochloride (pH 2.5), as described by Luckevich and Beveridge (1989) to extract specifically the cell-surface-anchored proteins.
  • the samples were centrifuged 10 min at 10,000 rpm, the pellets containing the bacterial cells and the supernatants containing the extracted proteins were then precipitated by adding trichloroacetic acid (TCA) to a final concentration of 10% (20 min at -20 0 C), centrifuged 10 min at 10,000 rpm, washed two times with water and suspended in 0.03 N NaOH. An equal volume of Laemmli sample loading buffer 2X was added. Samples were boiled for 5 min and loaded in two 10% SDS-PAGE gels.
  • TCA trichloroacetic acid
  • PVDF polyvinylidene difluoride
  • the ISLP1 strain was characterized by PCR reactions using general and specific primers for cry1, cry3, cry ⁇ , cry7, cry ⁇ , cry9, cry11, cry13, cry14, and cyt1A genes (Bravo et al., 1998; Ceron et al., 1994; Ceron et al., 1995). All PCR reactions were negative.
  • the 16S RNAr gene of the ISLP1 strain was then amplified using the primers designed by Aguino de Muro and Priest (Aguino de Muro and Priest, 1993). Blast analysis of the 16S DNA sequence confirmed that the ISLP1 strain belongs to the Bacillus thuringiensis group.
  • the 100 kDa protein produced by the ISLP 1 strain was purified by anion exchange chromatography, transferred to lmmobilon PSQ, and the amino-terminal sequence of the protein was obtained.
  • This amino acid sequence (AGKS FPDVPAG H, SEQ ID NO: 14) corresponds to the first 12 amino acids after the leader-peptide of an S-layer protein precursor from B. licheniformis OlpA (GenBank accession number U38842, GenPept accession number AAC44405) and B.anthracis EA1 (GenBank accession number X99724, GenPept accession number CAA68063).
  • PCR primers (ISLPIXder and ISLPIXrev) were designed from the two obtained N-terminal sequences of this protein and used for amplification of an internal fragment that was DNA sequenced. Blast analysis of the resulting sequence showed a high score with sequences of two S-layer genes o/pA and eag (GenBank accession numbers u38842 and X99724). Using this information and the DNA sequence alignment of these genes, novel PCR primers were designed to amplify two other overlapping PCR-products. One includes 500 bp upstream of the ATG codon in order to have the putative promoter, and the other included 200 bp after the putative stop codon.
  • the sequence of the complete islpi gene was obtained (SEQ ID NO: 1).
  • the open reading frame (ORF) found in this sequence contained 2,589 nucleotides, it was preceded by a Shine-Dalgarno sequence. A palindromic structure was observed 22 nucleotides downstream from the stop codon.
  • the comparison of the N-terminus of the sequenced protein and of the amino acid sequence deduced from the nucleotide sequence confirmed that this protein is also synthesized as a pre-polypeptide with a 29 amino acid signal peptide.
  • the N-terminus of the mature protein with signal sequence removed is at amino acid position 30 in SEQ ID NO: 2.
  • SSH S-Layer homology motifs
  • the complete islpi gene was cloned directly into acrystalliferous S. thu ⁇ ngiensis strain 407, by amplifying three PCR fragments that overlap in a Ncol and a Pst1 restriction site, respectively, as described in the Materials and Methods. It was not possible to obtain E. coli transformants with this construct. Other authors found that in many cases the cloning of the S-layer gene in E. coli with its regulatory region could lead to problems (Mesnage et al., 2001 ; Sun et al., 2001). The resulting Bt strain expressed the ISLP1 protein as judged by immunodetection of the protein using a polyclonal antibody raised against the pure ISLP1 protein.
  • a sporulated culture of this strain showed 100 % mortality of E.va ⁇ vestis larvae when assayed at 100 and 1000 ng/cm2 in contrast with the control strain transformed with the pHT315 shuttle vector that does not express the ISLP1 protein and did not show any toxicity to E. varivestis larvae.
  • the ISLP1 protein was expressed during the vegetative and the sporulation phase of growth. During vegetative phase of growth the protein was associated to the bacteria since all the protein detected by Western blot was found in the bacterial pellet obtained after centrifugation of the culture. However, during the sporulation phase the ISLP1 protein was also found in the supernatant of centrifuged cultures.
  • Luckevich and Beveridge (1989) described a specific extraction procedure for the S- Layer protein of B. thuringiensis subsp. galleria. We used this method to test whether the ISLP1 protein has the ability to bind to the cell surface from the original strain and in the transformant strain. Treatment of vegetative cells with 2 M chaotropic agent at low pH resulted in the specific extraction of the SL-1SLP1 protein as judged by the SDS-PAGE and the Western Blot analysis of the extracted protein. The SL-ISLP1 protein was only present in the ISLP 1 strain and the Bt-transformant strain, this protein was absent in the 407 acrystalliferous strain.
  • the ISLP1 protein was extracted only with the treatment of 2 M chaotropic reagent, treatments with lower concentrations of chaotropic reagent (1 - 1.5 M) did not extract the protein from the bacteria cells.
  • the ISLP1 protein (SEQ ID NO: 2) has high sequence identity to the EA1 S-layer protein from Bacillus anthracis (92 % sequence identity for the protein including the signal peptide) and to the CTC2 protein reported in B. thuringiensis (89 % sequence identity for the protein including the signal peptide).
  • the amino acid sequence identity of the ISLP1 protein to the other ⁇ . anthracis S-layer protein SAP is only 32 %.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Insects & Arthropods (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des protéines pesticides, et plus spécifiquement insecticides, lesquelles ressemblent à des protéines de couche S ainsi que des variantes ou mutantes de celles-ci et des ADN codant ces protéines. L'invention concerne également des procédés et moyens permettant d'utiliser cet ADN ou cette protéine pour la maîtrise des animaux nuisibles et plus spécifiquement des insectes nuisibles aux plantes. L'accent est mis sur le fait que cet abrégé est conforme aux règles qui requièrent un abrégé permettant à un chercheur ou à tout autre lecteur de rapidement évaluer l'objet de la divulgation technique. Il est entendu que cet abrégé ne sera pas utilisé pour interpréter ou limiter le but ou la signification des revendications.
EP06795076.6A 2005-07-08 2006-07-04 Nouvelles proteines bacteriennes avec activite pesticide Active EP1904521B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69739105P 2005-07-08 2005-07-08
PCT/IB2006/001856 WO2007007147A2 (fr) 2005-07-08 2006-07-04 Nouvelles proteines bacteriennes avec activite pesticide

Publications (2)

Publication Number Publication Date
EP1904521A2 true EP1904521A2 (fr) 2008-04-02
EP1904521B1 EP1904521B1 (fr) 2013-08-21

Family

ID=37637544

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06795076.6A Active EP1904521B1 (fr) 2005-07-08 2006-07-04 Nouvelles proteines bacteriennes avec activite pesticide

Country Status (7)

Country Link
US (3) US8173871B2 (fr)
EP (1) EP1904521B1 (fr)
CN (1) CN101300268A (fr)
BR (1) BRPI0613111A2 (fr)
CA (1) CA2625061A1 (fr)
ES (1) ES2435079T3 (fr)
WO (1) WO2007007147A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120088719A1 (en) 2010-09-20 2012-04-12 Jerald Coleman Ensign Mosquitocidal Xenorhabdus, Lipopeptide And Methods
EP2630263B2 (fr) 2010-10-22 2021-11-10 Cold Spring Harbor Laboratory Comptage variétal d'acides nucléiques pour obtenir des informations sur le nombre de copies génomiques
CN106937674B (zh) * 2017-01-20 2024-01-30 江苏省农业科学院 用于肉品保鲜的抗菌剂

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4407956A (en) 1981-03-13 1983-10-04 The Regents Of The University Of California Cloned cauliflower mosaic virus DNA as a plant vehicle
CA1192510A (fr) 1981-05-27 1985-08-27 Lawrence E. Pelcher Vecteur de arn virale de virus des plantes ou portion de ce vecteur, methode de construction, et methode de production d'un gene derive
NL8200523A (nl) 1982-02-11 1983-09-01 Univ Leiden Werkwijze voor het in vitro transformeren van planteprotoplasten met plasmide-dna.
US4536475A (en) 1982-10-05 1985-08-20 Phytogen Plant vector
EP0290799B9 (fr) 1983-01-13 2004-09-01 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Cellules de plantes et des plantes dicotyledones transgéniques
JPH0714349B2 (ja) 1983-01-17 1995-02-22 モンサント カンパニ− 植物細胞での発現に適したキメラ遺伝子
DE3464841D1 (en) 1983-01-27 1987-08-27 Gen Foods Corp Water-agglomeration method for depeptide sweetened products
NL8300699A (nl) 1983-02-24 1984-09-17 Univ Leiden Werkwijze voor het inbouwen van vreemd dna in het genoom van tweezaadlobbige planten; werkwijze voor het produceren van agrobacterium tumefaciens bacterien; stabiele cointegraat plasmiden; planten en plantecellen met gewijzigde genetische eigenschappen; werkwijze voor het bereiden van chemische en/of farmaceutische produkten.
WO1985001856A1 (fr) 1983-11-03 1985-05-09 Johannes Martenis Jacob De Wet Procede de transfert de genes exogenes dans des plantes en utilisant le pollen comme vecteur
US5447858A (en) 1984-04-13 1995-09-05 Mycogen Plant Sciences, Inc. Heat shock promoter and gene
US5254799A (en) 1985-01-18 1993-10-19 Plant Genetic Systems N.V. Transformation vectors allowing expression of Bacillus thuringiensis endotoxins in plants
BR8600161A (pt) 1985-01-18 1986-09-23 Plant Genetic Systems Nv Gene quimerico,vetores de plasmidio hibrido,intermediario,processo para controlar insetos em agricultura ou horticultura,composicao inseticida,processo para transformar celulas de plantas para expressar uma toxina de polipeptideo produzida por bacillus thuringiensis,planta,semente de planta,cultura de celulas e plasmidio
FI864720A (fi) 1985-11-22 1987-05-23 Ciba Geigy Ag Direkt gentransmission i plasticider och mitokondrier.
DE3765449D1 (de) 1986-03-11 1990-11-15 Plant Genetic Systems Nv Durch gentechnologie erhaltene und gegen glutaminsynthetase-inhibitoren resistente pflanzenzellen.
EP0265556A1 (fr) 1986-10-31 1988-05-04 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Vecteurs binaires stables pour l'agrobactérium et leur utilisation
IL84459A (en) 1986-12-05 1993-07-08 Agracetus Apparatus and method for the injection of carrier particles carrying genetic material into living cells
TR27832A (tr) * 1987-04-29 1995-08-31 Monsanto Co Zararli ucucu hasarata mukavim bitkiler.
CA1339684C (fr) 1988-05-17 1998-02-24 Peter H. Quail Systeme de collecte de l'ubiquitine vegetale
NZ230375A (en) 1988-09-09 1991-07-26 Lubrizol Genetics Inc Synthetic gene encoding b. thuringiensis insecticidal protein
US5693507A (en) 1988-09-26 1997-12-02 Auburn University Genetic engineering of plant chloroplasts
EP0447493A1 (fr) 1988-12-12 1991-09-25 Plant Genetic Systems, N.V. Nouvelle souche de bacillus thuringiensis
ES2164633T3 (es) 1989-02-24 2002-03-01 Monsanto Technology Llc Genes vegetales sinteticos y procedimiento para su preparacion.
EP0400246A1 (fr) 1989-05-31 1990-12-05 Plant Genetic Systems, N.V. Prévention du développement de la résistance au Bt
US5641876A (en) 1990-01-05 1997-06-24 Cornell Research Foundation, Inc. Rice actin gene and promoter
JPH05506578A (ja) 1990-04-18 1993-09-30 プラント・ジエネテイツク・システムズ・エヌ・ベー 変性ｂａｃｉｌｌｕｓ　ｔｈｕｒｉｎｇｉｅｎｓｉｓ殺虫性結晶タンパク質遺伝子及びそれらの植物細胞中での発現
CA2096843C (fr) 1990-11-23 2007-08-07 Kathleen D'halluin Procede pour la transformation de plantes monocotyledones
FR2673643B1 (fr) 1991-03-05 1993-05-21 Rhone Poulenc Agrochimie Peptide de transit pour l'insertion d'un gene etranger dans un gene vegetal et plantes transformees en utilisant ce peptide.
CA2122261A1 (fr) 1991-10-30 1993-05-13 Marc Cornelissen Genes modifies et leur expression dans des cellules vegetales
US5593874A (en) 1992-03-19 1997-01-14 Monsanto Company Enhanced expression in plants
US5591616A (en) 1992-07-07 1997-01-07 Japan Tobacco, Inc. Method for transforming monocotyledons
US5877012A (en) 1993-03-25 1999-03-02 Novartis Finance Corporation Class of proteins for the control of plant pests
US5849870A (en) 1993-03-25 1998-12-15 Novartis Finance Corporation Pesticidal proteins and strains
WO1995006722A1 (fr) 1993-09-03 1995-03-09 Japan Tobacco Inc. Procede permettant de transformer une monocotyledone avec un scutellum d'embryon immature
FR2712302B1 (fr) 1993-11-10 1996-01-05 Rhone Poulenc Agrochimie Eléments promoteurs de gènes chimères de tubuline alpha.
US5689052A (en) 1993-12-22 1997-11-18 Monsanto Company Synthetic DNA sequences having enhanced expression in monocotyledonous plants and method for preparation thereof
US5633363A (en) 1994-06-03 1997-05-27 Iowa State University, Research Foundation In Root preferential promoter
NZ291734A (en) 1994-08-30 1997-09-22 Commw Scient Ind Res Org Plant transcription regulators from circovirus; isolated nucleic acid molecules and transgenic plants
WO1997048819A1 (fr) 1996-06-20 1997-12-24 The Scripps Research Institute Promoteurs du virus de la mosaique des nervures du manioc et leurs utilisations
AU2829997A (en) 1996-08-29 1998-03-19 Dowelanco Insecticidal protein toxins from (photorhabdus)
US6017534A (en) 1996-11-20 2000-01-25 Ecogen, Inc. Hybrid Bacillus thuringiensis δ-endotoxins with novel broad-spectrum insecticidal activity
CA2272843C (fr) 1996-11-20 2009-11-10 Ecogen, Inc. Endotoxines delta a large spectre
CN1155715C (zh) 1997-02-20 2004-06-30 植物遗传系统有限公司 植物转化的改良方法
WO1998044137A2 (fr) 1997-04-03 1998-10-08 Novartis Ag Lutte contre des ennemis des plantes
EP0915909B1 (fr) 1997-05-05 2007-06-13 Dow AgroSciences LLC Toxines proteiques insecticides issues de xenorhabdus
US6218188B1 (en) 1997-11-12 2001-04-17 Mycogen Corporation Plant-optimized genes encoding pesticidal toxins
US6489542B1 (en) 1998-11-04 2002-12-03 Monsanto Technology Llc Methods for transforming plants to express Cry2Ab δ-endotoxins targeted to the plastids
ES2288478T3 (es) 1999-05-19 2008-01-16 Bayer Bioscience N.V. Metodo mejorado para la transformacion de algodon, mediada por agrobacterium.
ES2321375T3 (es) 1999-12-28 2009-06-05 Bayer Bioscience N.V. Proteinas insecticidas de bacillus thuringiensis.
EP1280828B1 (fr) * 2000-04-28 2006-09-13 Tetracore, Inc. Antigene specifique du charbon, vaccin le comprenant, anticorps specifiques et leurs utilisations
BRPI0206346B1 (pt) 2001-01-09 2018-04-03 Bayer Cropscience Nv Dna que codifica uma proteína inseticida cry2ae, gene quimérico compreendendo o mesmo, proteína inseticida, uso da mesma, micro-organismo, bem como processo para tornar uma planta resistente a um inseto lepidóptero
FR2822157B1 (fr) 2001-03-19 2003-10-31 Aventis Cropscience Sa Toxine insecticide de bacillus thuringiensis modifiee sensible a la pepsine
US20030208789A1 (en) 2002-05-03 2003-11-06 Stefan Jansens Wound-inducible expression in plants

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2007007147A2 *

Also Published As

Publication number Publication date
US20140304855A1 (en) 2014-10-09
CN101300268A (zh) 2008-11-05
US20090144854A1 (en) 2009-06-04
US8173871B2 (en) 2012-05-08
WO2007007147A2 (fr) 2007-01-18
BRPI0613111A2 (pt) 2010-12-21
US8822157B2 (en) 2014-09-02
ES2435079T3 (es) 2013-12-18
US20120255065A1 (en) 2012-10-04
CA2625061A1 (fr) 2007-01-18
EP1904521B1 (fr) 2013-08-21
WO2007007147A3 (fr) 2007-06-14

Similar Documents

Publication Publication Date Title
US9909140B2 (en) AXMI-115, AXMI-113, AXMI-005, AXMI-163 and AXMI-184: insecticidal proteins and methods for their use
US8237021B2 (en) Insecticidal proteins derived from Bacillus thuringiensis
AU2004213873B2 (en) Delta-endotoxin genes and methods for their use
JP2019141078A (ja) Ａｘｍｉ４７７、ａｘｍｉ４８２、ａｘｍｉ４８６およびａｘｍｉ５２５毒素遺伝子およびそれらの使用方法
US8822157B2 (en) Bacterial proteins with pesticidal activity
US7919609B2 (en) Toxins
EP1490397B1 (fr) Nouvelles proteines insecticides issues du bacillus thuringiensis
WO2006058760A2 (fr) Proteines insecticides bacteriennes
CA2924415A1 (fr) Nouveaux genes codant pour des proteines a action insecticide

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080208

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20080624

DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 628045

Country of ref document: AT

Kind code of ref document: T

Effective date: 20130915

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602006038014

Country of ref document: DE

Effective date: 20131017

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2435079

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20131218

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 628045

Country of ref document: AT

Kind code of ref document: T

Effective date: 20130821

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20130821

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130821

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131223

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130821

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130821

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130703

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131221

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130821

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130821

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130821

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130821

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130821

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131122

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130821

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130821

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130821

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130821

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130821

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130821

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130821

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130821

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20140522

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602006038014

Country of ref document: DE

Effective date: 20140522

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602006038014

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140704

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20140704

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20150331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140731

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150203

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140731

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602006038014

Country of ref document: DE

Effective date: 20150203

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140731

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140704

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140704

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130821

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130821

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20060704

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130821

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20230816

Year of fee payment: 18